⌘K

Login Start Free

Home/Filings/4/0001214659-22-000264

4//SEC Filing

Durrant Cameron 4

Accession 0001214659-22-000264

CIK 0001293310other

View on SEC.gov Company Profile

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 6:20 PM ET

Size

5.4 KB

Accession

0001214659-22-000264

Insider Transaction Report

Form 4

Period: 2021-12-31

HUMANIGEN, INCHGEN

Durrant Cameron

Director

Transactions

Award
Stock Option (Right to Buy)
2021-12-31+76,000→ 76,000 total
Exercise: $3.72From: 2022-03-31Exp: 2031-12-30→ Common Stock (76,000 underlying)

Footnotes (1)

[F1]The option vests in 12 ratable quarterly installments commencing March 31, 2022.

Documents

1 file

4
marketforms-54934.xmlPrimary
PRIMARY DOCUMENT

Issuer

HUMANIGEN, INC

CIK 0001293310

Entity typeother

Related Parties

1

filerCIK 0001421882

Filing Metadata

Form type: 4
Filed: Jan 3, 7:00 PM ET
Accepted: Jan 4, 6:20 PM ET
Size: 5.4 KB

View on SEC.gov